Press Releases

See below for all our latest press releases. 

New Board Appointments Announcement

PDF, 215 KB

DeepMatter is pleased to announce two appointments to the Board, effective on 1 November 2020. Karen Bach will join as Non-Executive Chair and Fraser Benson will join as Chief Financial Officer.

Strong adoption of ICSYNTH

PDF, 210.4 KB

DeepMatter doubles customer numbers for its machine-learning retrosynthesis tool ICSYNTH

AstraZeneca Collaboration Release

PDF, 58.3 KB

DeepMatter announces collaboration with AstraZeneca focused on improving productivity of compound synthesis using digital technologies enabled with machine learning and artificial intelligence

O2H Release

PDF, 57 KB

Having parcipated in the Pioneer Programme, and being sufficiently impressed by the DigitalGlassware™ technology, o2h has elected to pay for the provision of a greater number of user licences. This roll out will enable o2h to use DigitalGlassware™ as part its drug-discovery collaboration with a strategic customer.

University of Leeds Collaboration Release

PDF, 64.7 KB

DeepMatter and the Institute of Process Research and Development (iPRD) at the University of Leeds, have commenced a project to integrate DeepMatter's technology platform, DigitalGlassware™ within the iPRD's laboratories

University Of Nottingham Collaboration Release

PDF, 71.5 KB

DeepMatter is delighted to be collaborating with the University of Nottingham's School of Chemistry, to explore the benefits of the DigitalGlassware™ platform in data capture and analysis within undergraduate chemistry teaching

Waters Press Release

PDF, 75.1 KB

DeepMatter announces plans to interface its DigitalGlassware™ platform with the Waters Corporation UNIFI™ Scientific Information System, enhancing the quality and accessibility of data for chemists worldwide.

Cancer Research UK Beatson Institute Press Release

PDF, 69.8 KB

DeepMatter announces collaboration with the Cancer Research UK Beatson Institute within its Drug Discovery Unit to enhance the reproducibility of its chemistry and accelerate drug discovery